Author Archives: Dr. June Lee

Spravato Esketamine: What We Know So Far

FDA approved a new nasal spray medication for treatment-resistant depression called Spravato, trade name for Esketamine on March 5, 2019.  We’ve had many inquiries about the medication at our practice and I thought it would be beneficial to all of you to share the information I have regarding this new medication. Spravato is a new antidepressant medication manufactured by Johnson & Johnson’s pharmaceutical company, Janssen, for management of Treatment Resistant Depression. According to the FDA, “Patients with major depressive disorder …
Read More »

Posted in Blog, Ketamine Treatment | Tagged , , | Leave a comment

Premenstrual Dysphoric Disorder: How Ketamine May Help

Photo Credit: Dmitry Schemelev Premenstrual Dysphoric Disorder Premenstrual dysphoric disorder (PMDD), a severe mood disorder, is characterized by mental health and physical symptoms in the week before the onset of menstruation and affects millions of women worldwide[i]. It is a much more intense form of PMS. Emotional and mood related symptoms include: • Mood swings, tearfulness, sensitivity to rejection • Irritability or anger • Marked depressed mood, hopelessness, self-depreciating thoughts • Anxiety or tension • Loss of interest in usual activities …
Read More »

Posted in Blog, Depression | Tagged , | Leave a comment